Skip to main content
EuroAPI logo

EuroAPI — Investor Relations & Filings

Ticker · EAPI ISIN · FR0014008VX5 LEI · 9695002FT7GGI3CKKJ14 PA Manufacturing
Open in API
Filings indexed 186 across all filing types
Latest filing 2026-04-30 Transaction in Own Shar…
Country FR France
Listing PA EAPI

About EuroAPI

https://www.euroapi.com/en

EuroAPI is a developer and manufacturer of Active Pharmaceutical Ingredients (APIs), focusing on small and complex molecules. The company's business is centered on two main activities: offering API solutions from its large portfolio and providing Contract Development and Manufacturing Organization (CDMO) services. The product portfolio contains over 200 ingredients, with expertise in categories such as opiates and controlled substances, prostaglandins, corticoids, hormones, anti-infectives, and Vitamin B12. As a CDMO, EuroAPI provides services for complex chemistry, including small molecule synthesis, microbial fermentation, particle engineering (micronization and spray drying), and the development of lipids and tides like oligonucleotides, serving a global customer base.

Recent filings

Filing Released Lang Actions
EUROAPI_Contrat de liquidité
Transaction in Own Shares
2026-04-30 French
EUROAPI_Liquidity Contract
Transaction in Own Shares
2026-04-30 English
Modalité de mise à disposition des documents préparatoires à l'AG 2026
AGM Information Classification · 1% confidence The document is a press release dated April 29, 2026, informing shareholders about the upcoming Annual General Meeting (Assemblée Générale) on May 27, 2026 and detailing how to access the preparatory materials. It is not the full AGM materials themselves nor a report, but an announcement relating to the AGM. This fits the “AGM Information” category (Code: AGM-R).
2026-04-29 French
Availabilty of 2026 AGM preparatory documents
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a press release announcing the Combined General Meeting on May 27, 2026 and informing shareholders about the availability of preparatory (proxy) documents on the company’s website. It is not the meeting materials themselves (AGM presentations), nor is it reporting results, financials, or regulatory compliance. Under our taxonomy, communications providing information and soliciting votes for a shareholders’ meeting are classified as Proxy Solicitation & Information Statement (PSI).
2026-04-29 English
EUROAPI - Mise à disposition du Document d’Enregistrement Universel 2025
Report Publication Announcement Classification · 1% confidence The document is a press release dated March 27, 2026 announcing that EUROAPI’s Universal Registration Document 2025 (containing the annual financial report, audit reports, management report, etc.) has been filed with the AMF and is now available on the company and AMF websites. The full report is not included in this text. The notice simply informs investors and the public about the availability of the report. Under the “menu vs meal” rule, this is an announcement of a report’s publication rather than the report itself. Therefore, it should be classified as a Report Publication Announcement (RPA).
2026-03-27 French
EUROAPI - Availability of the 2025 Universal Registration Document
Report Publication Announcement Classification · 1% confidence The document is a press release announcing the publication and availability of the company’s 2025 Universal Registration Document (which contains the annual financial report, management report, auditors’ reports, etc.) and provides links to access it. It does not contain the full report itself, only a notice of its availability. Therefore, it is a Report Publication Announcement.
2026-03-27 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.